InvestorsHub Logo
Followers 38
Posts 2980
Boards Moderated 0
Alias Born 01/14/2003

Re: Biobillionair post# 13888

Saturday, 09/14/2013 3:58:44 PM

Saturday, September 14, 2013 3:58:44 PM

Post# of 428666
the plan was(is?) pronova was(is?) going to provide the API for the generic lovaza/omacor as well. remember, pronova only cares(ed) about the $0.15-0.20 pronova generates(ed) per gram of API, not the $1.20-$1.50/gram the drug marketer obtains at the endpoint.

i do not know how(if?) the BASF acquisition changed these plans.
pronova was never going to be squeezed by the introduction of
generic lovaza/omacor, it was always the drug marketer who was
going to be squeezed.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News